Meet our Leadership Team
Our Leadership Team are reshaping the future direction of TPD drug development. Their combined skills and experience from leading Pharma and Biotech companies is empowering Amphista to achieve its vision of delivering TPD medicines to patients.
Ian Churcher
CSO
Martin Pass
CDO
Wendy Nicholson
Head of BioCity and Head of Compliance & Governance
Julia Jones
Finance Director
Martin O’Rourke
VP of Drug Discovery
Stuart Wood
VP, Discovery Technology
Hanna Dickenson
VP of Portfolio Management and Corporate Planning
Andrea Testa
Director of Exploratory Chemistry
Scott Hughes
Director of Exploratory Biology
James Osborne
Director of Medicinal Chemistry
Diane Simmons
Director of Operations & Strategic Projects
Helen Harrison
Director of Screening
Liliana Greger
Director of Bioinformatics
